Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)

Annals of Oncology

Volumn 9, Issue SUPPL. 5, 1998, Pages

  Rudiger T ^a,m   Jaffe, E S ^b   Delsol, G ^c   DeWolf Peeters, C ^d   Gascoyne, R D ^e   Georgii, A ^f   Harris, N L ^g   Kadin, M E ^h   MacLennan, K A ⁱ   Poppema, S ^j   Stein, H ^k   Weiss, L E ^l   Muller Hermelink H K ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHU PURPAN   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^j UNIVERSITY OF GRONINGEN   (Netherlands)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^m Institute of Pathology   (Germany)

more..

Author keywords

Differential diagnosis; Grey zone; Hodgkin's lymphoma; Immunohistochemistry; Pathology; Workshop report

Indexed keywords

ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; B CELL LYMPHOMA; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HODGKIN DISEASE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MOLECULAR BIOLOGY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0032448336     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/9.suppl_5.S31     Document Type: Conference Paper

References (22)

1. Küppers R, Kanzler H, Hansmann ML et ai. Single-cell analysis of Hodgkin/Reed-Sternberg cells. Ann Oncol 1996; 7 (Suppl 4): 27-30.
2. Küppers R, Rajewsky K, Zhao M et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91 (23): 10962-6.
3. Marafioti T, Hummel M, Anagnostopoulos I et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells (see comments). N Engl J Med 1997; 337 (7): 453-8.
4. Pulford K, Lamant L, Morris SW et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997; 89 (4): 1394-404.
5. Krenacs L, Wellmann A, Sorbara L et al. Cytotoxic cell antigen expression in anaplastic large-cell lymphomas of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin. Blood 1997; 89 (3): 980-9.
6. Bcnharroch D, Megucrian-Bcdoyan Z, Lamant L et al. ALK-positive lymphoma. A single disease with a broad spectrum of morphology. Blood 1998; 91 (6): 2076-84.
7. Kamel OW. latrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diagn Pathol 1997; 14 (1): 27-34.
8. Jaffe ES, Harris NL, Chan JKC et al. Society for hematopathology program. Proposed World Health Organization Classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol 1997; 21 (1): 114-21.
9. Harris NL, Jaffe ES, Stein H et al. A Revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84 (5): 1361-92.
10. Shiota M, Nakamura S, Ichinohasama R et al. Anaplastic large-cell lymphomas expressing the novel chimeric protein pSONPM/ALK: A distinct clinicopathologic entity. Blood 1995; 86 (5): 1954-60.
11. Rüdiger T, Ott G, Ott MM et al. Differential diagnosis between classical Hodgkin's lymphoma, T-cell rich B-cell lymphoma and Paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol 1998 (in press).
12. Zukerberg LR, Collins AB, Ferry JA et al. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 1991; 139 (3): 475-83.
13. Warnke RA, Weiss LM, Chan JKC et al. Tumors of the lymph nodes and spleen. In Rosai J, Sobin LH (eds): Atlas of Tumor Pathology. Vol. Fascicle 14. Washington DC: Armed Forces Institute of Pathology 1995.
14. Schmid C, Pan L, Diss T et al. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 1991; 139 (4): 701-7.
15. Korkopoulou P, Cordell J, Jones M et al. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 1994; 24 (6): 511-5.
16. Foss HD, Anagnostopoulos I, Araujo I et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88 (10): 4005-11.
17. von Wasielewski R, Mengel M, Fischer R et al. Classical Hodgkin's disease clinical impact of the immunophenotype. Am J Pathol 1997; 151 (4): 1123-30.
18. Orscheschek K, Merz H, Hell J et al. Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis? (see comments) Lancet 1995; 345 (8942) 87-90.
19. Shiota M, Mori S. Anaplastic large-cell lymphomas expressing the novel chimeric protein pSONPM/ALK.: A distinct clinicopathologic entity. Leukemia 1997; 11 (Suppl 3): 538-10.
20. Pinkus GS, Pinkus JL, Langhoff E et al. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B-cell derivation? Am J Pathol 1997; 150 (2): 543-62.
21. Kamel OW, Gelb AB, Shibuya RB et al. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell rich B-cell lymphoma and follicular lymphoma. Am J Pathol 1993; 142 (2): 541-6.
22. Kim H. Composite lymphoma and related disorders. Am J Clin Pathol 1993; 99 (4): 445-51.